The corona pandemic is ravaging India and the world. The unparalleled race to come out with a rudimentary vaccine is now being matched by the speed with which rich nations like the US and the UK are entering into advance purchase agreements with global vaccine makers. Since India is the third-largest producer of generic medicines at the lowest cost and has capacities to manufacture three billion doses of vaccine annually, it is time the government at the Centre put in place a rational and objective strategy to ensure fair and equitable access to Covid-19 vaccine for everybody.
With surging number of